SARS CoV 2 News and Research

RSS

Antenatal COVID-19 vaccination shown to be safe for pregnant women and their babies

A study in Obstetrics & Gynecology finds that antenatal COVID-19 vaccination does not increase the risk of adverse pregnancy outcomes, confirming vaccine safety for pregnant women.

12 Jun 2024

Study finds short-term side effects of COVID-19 mRNA vaccines boost long-term antibody response

Short-term adverse effects of COVID-19 mRNA vaccinations are linked to higher and longer-lasting neutralizing antibody responses, indicating robust immune efficacy.

11 Jun 2024

Attenuated virus helps eliminate cancer in mice

Northwestern Medicine scientists have discovered that an attenuated (weakened) virus can help eliminate cancer in mice.

11 Jun 2024

Sperm counts may not be declining globally, study suggests

The widely held view that sperm counts in men are dropping around the world may be wrong, according to a new study by University of Manchester, Queen’s University in Kingston, Canada and Cryos International, Denmark.

8 Jun 2024

Stanford study finds 15-day paxlovid treatment safe but ineffective for long COVID

In a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day course of Paxlovid -; an antiviral drug combination targeting SARS-CoV-2, the virus that causes COVID-19 -; proved safe as an extended-duration treatment but didn't lessen select symptoms of the syndrome known as long COVID: the persistence, or reappearance, of COVID-related symptoms three months or more after an initial COVID-19 infection.

7 Jun 2024

Innovative therapeutic strategies for combating type 2 diabetes

One of the most confusing aspects for patients with type 2 diabetes mellitus is that they have high fasting glucose levels.

7 Jun 2024

Three-year analysis of COVID-19's impact reveals persistent excess mortality in the Western world

Excess death rates have remained high in the West for three years running since the start of the COVID-19 pandemic, finds a data analysis of 47 countries published in the open access journal BMJ Public Health.

5 Jun 2024

Fertility warning: SARS-CoV-2 can linger in sperm for months after infection

Researchers at the University of São Paulo (USP) in Brazil have shown for the first time that SARS-CoV-2, the virus that causes COVID-19, can remain in the sperm of patients for up to 90 days after hospital discharge and up to 110 days after the initial infection, reducing semen quality.

4 Jun 2024

Novel small molecule oral antiviral could be a game-changer in the fight against future pandemics

Obeldesivir (GS-5245), a novel investigational small molecule oral antiviral, represents a new tool in the ongoing effort to prepare for future pandemics.

4 Jun 2024

Long COVID linked to higher risk of erectile dysfunction, new study finds

The risk of developing erectile dysfunction (ED) following a diagnosis of long coronavirus disease (COVID) compared to acute COVID.

4 Jun 2024

N95 respirators potential standard of care in nursing homes and healthcare settings during respiratory viral infections

Researchers examined the efficiency of surgical masks, fabric masks, N95 respirators, and KN95 respirators in lowering the SARS-CoV-2 viral loads in the exhaled breath aerosol samples of COVID-19 patients.

4 Jun 2024

IgG from long COVID patients induces specific symptoms in mice, confirming autoimmunity's role

Researchers found that IgG from long COVID patients induces specific symptoms in mice, suggesting IgG's role in long COVID pathogenesis.

3 Jun 2024

Long-term health risks linger for severe COVID-19 patients three years after hospitalization

Three years after severe COVID-19 hospitalization, significant risks of mortality and long-term symptoms persist, impacting overall health and quality of life.

2 Jun 2024

Super-resolution microscopy offers high-resolution view of virus replication inside cells

A new, nano-scale look at how the SARS-CoV-2 virus replicates in cells may offer greater precision in drug development, a Stanford University team reports in Nature Communications.

31 May 2024

TMPRSS2 protein facilitates SARS-CoV-2 entry via unexpected pathway

How exactly do Sars-Cov-2 particles enter host cells? An international team led by Dr Richard Brown from Dr Daniel Todt's Computational Virology group at the Department of Molecular and Medical Virology at Ruhr University Bochum, Germany, together with researchers from the Paul-Ehrlich-Institut, investigated this question.

31 May 2024

COVID-19 associated with higher risk of erectile dysfunction

Men previously diagnosed with COVID-19 are at a greater risk of developing new-onset erectile dysfunction.

31 May 2024

Three-year study shows lingering effects of COVID-19

New findings on long COVID -; long-term effects on health experienced by many who have had COVID-19 -; present a good-news, bad-news situation, according to a study at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system.

30 May 2024

Inexpensive “duckbill” N95 becomes the champion in COVID-19 mask effectiveness

In a head-to-head comparison of masks worn by people with active COVID-19, the inexpensive "duckbill" N95 came out on top, stopping 98% of COVID-19 particles in the breath of infected people from escaping into the air.

30 May 2024

Pregnant women less likely to suffer long COVID, study finds

A new study in EClinicalMedicine found that SARS-CoV-2 infection during pregnancy is linked to a lower risk of developing post-acute sequelae (PASC) compared to infection outside of pregnancy.

29 May 2024

COVID-19 boosters targeting omicron subvariants remain effective, but wane over time

Boosters that target the omicron subvariants of SARS-CoV-2 are still providing reasonably durable protection against infection, hospitalization and death from COVID-19, according to new data from a study led by researchers at the UNC Gillings School of Global Public Health.

29 May 2024

SARS CoV 2 News and Research

Antenatal COVID-19 vaccination shown to be safe for pregnant women and their babies

Study finds short-term side effects of COVID-19 mRNA vaccines boost long-term antibody response

Attenuated virus helps eliminate cancer in mice

Sperm counts may not be declining globally, study suggests

Stanford study finds 15-day paxlovid treatment safe but ineffective for long COVID

Innovative therapeutic strategies for combating type 2 diabetes

Three-year analysis of COVID-19's impact reveals persistent excess mortality in the Western world

Fertility warning: SARS-CoV-2 can linger in sperm for months after infection

Novel small molecule oral antiviral could be a game-changer in the fight against future pandemics

Long COVID linked to higher risk of erectile dysfunction, new study finds

N95 respirators potential standard of care in nursing homes and healthcare settings during respiratory viral infections

IgG from long COVID patients induces specific symptoms in mice, confirming autoimmunity's role

Long-term health risks linger for severe COVID-19 patients three years after hospitalization

Super-resolution microscopy offers high-resolution view of virus replication inside cells

TMPRSS2 protein facilitates SARS-CoV-2 entry via unexpected pathway

COVID-19 associated with higher risk of erectile dysfunction

Three-year study shows lingering effects of COVID-19

Inexpensive “duckbill” N95 becomes the champion in COVID-19 mask effectiveness

Pregnant women less likely to suffer long COVID, study finds

COVID-19 boosters targeting omicron subvariants remain effective, but wane over time

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Latest News